Fate Therapeutics (FATE) EBITDA Margin Growth (1y) (2013 - 2026)
Fate Therapeutics (FATE) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Fate Therapeutics |
250.86 Mn |
250.86 Mn |
- |
-10,353.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-10,353.00 |
| Dec 31, 2025 |
46,691.00 |
| Sep 30, 2025 |
-33,704.00 |
| Jun 30, 2025 |
-122,253.00 |
| Mar 31, 2025 |
19,039.00 |
| Dec 31, 2024 |
-23,250.00 |
| Sep 30, 2024 |
80,892.00 |
| Jun 30, 2024 |
507,721.00 |
| Mar 31, 2024 |
-247,461.00 |
| Dec 31, 2023 |
-247,799.00 |
| Sep 30, 2023 |
-176,209.00 |
| Jun 30, 2023 |
-523,486.00 |
| Mar 31, 2023 |
33,811.00 |
| Dec 31, 2022 |
28,214.00 |
| Sep 30, 2022 |
-25,258.00 |
| Jun 30, 2022 |
-338.00 |
| Mar 31, 2022 |
3,956.00 |
| Dec 31, 2021 |
-7,042.00 |
| Sep 30, 2021 |
47,621.00 |
| Jun 30, 2021 |
9,509.00 |
